All research files

Blends / RESEARCH PROTOCOL GUIDE

CJC-1295 (no DAC) + IPA

Blends · Research protocol guide

Growth-hormone signaling peptide blend. Combination dosing is not clinically established.

Catalog provenance checked October 18, 2026Independent research dossier

01 / RESEARCH SUMMARY

CJC-1295 (no DAC) + IPA Research Summary

This blend combines two growth hormone secretagogues that work through different receptors. CJC-1295 without DAC (modified GRF 1-29) is a GHRH analog that signals the pituitary to release growth hormone, with a half-life of about 30 minutes. Ipamorelin activates the ghrelin receptor, triggering a growth hormone pulse with little effect on cortisol or prolactin. Studies of GHRH and ghrelin-pathway agonists given together show a synergistic, larger GH release than either alone, which is the rationale for pairing them.

Read the full guide →

02 / WHY RESEARCHERS STUDY IT

Why CJC-1295 (no DAC) + IPA draws research interest

These are the areas researchers and the peptide community explore CJC-1295 (no DAC) + IPA for most often. They describe what is being studied — not proven benefits, approved uses, or promised results.

Bigger GH pulse

Two pathways together release more GH than either alone.

Body composition

Explored for lean mass and fat loss via GH and IGF-1.

Sleep & recovery

Studied for deep sleep and recovery tied to nightly GH.

Evidence ranges from early lab work to large clinical trials depending on the use — see the sections below for the data and sources.

03 / DOSING & RECONSTITUTION

Dosing & Reconstitution Guide

A single practical dilution with accurate dosing, step by step

Standard Approach (3 mL = 3.33 mg/mL)

  • Reconstitute: Add 3 mL bacteriostatic water to one 10 mg vial → final concentration 3.33 mg/mL (3,333.3 mcg/mL).
  • Typical range: 100–600 mcg 1–3x daily (am/workout/pm) · 5 on 2 off or daily, 3–6 months · fasted.
  • Easy measuring: At 3.33 mg/mL, 1 unit ≈ 33.33 mcg on a U-100 syringe, so doses read at 3–18 units — a 0.3 mL (30-unit) syringe makes them easier to read.
  • Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
ProtocolDose rangeFrequencyCycleTime offHalf-lifeFastedRoute
Injectable · Subq100–600 mcg1–3x daily (AM/Workout/PM) · 5 on 2 off or daily3–6 months4–8 weeksShort (both components)YesSubq

04 / RECONSTITUTION CALCULATOR

Mix & measure CJC-1295 (no DAC) + IPA · 10 mg

Pre-filled with this protocol's recommended BAC water and starting dose — edit any field to run your own numbers.

CONCENTRATION
3.33 mg/mL
DRAW VOLUME
0.030 mL
ON THE SYRINGE
3.0 units
DOSES / VIAL
100
3 units0102030405060708090100

Reconstitution math only. U-100 syringe: 100 units = 1 mL.

Reconstitution GuideFull calculator →

05 / STORAGE

Storage Instructions

Lyophilized (powder)

Store in the freezer at −20 °C (−4 °F) for long-term storage, or refrigerated at 2–8 °C for shorter periods. Keep dry, sealed and away from light. Let a frozen vial reach room temperature before opening to avoid condensation.

Reconstituted

Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days. Do not freeze. Keep away from heat and direct light, and avoid repeated temperature swings. Swirl gently — never shake.

Reconstitution steps

  1. Wipe the vial stopper with an alcohol swab.
  2. Draw the BAC water and release it slowly down the inside wall of the vial.
  3. Swirl or roll gently until fully dissolved — don't shake.
  4. Label with the date and concentration and refrigerate.
Read the full Reconstitution Guide →

06 / RESEARCH FINDINGS

What Research Shows

Unvalidated blend

  • Growth-hormone signaling is the intended research target of this combination; clinical recovery or muscle-gain benefits are not established here.
  • Benefits of a component do not demonstrate benefits of the finished blend.
Research context

The combination needs its own composition, compatibility, safety, and outcome data; no validated human benefit is established here.

07 / MOLECULAR BIOLOGY

Mechanism of Action

Mechanism unresolved

Proposed research targets

Growth-hormone signaling is the intended research target of this combination; clinical recovery or muscle-gain benefits are not established here.

The molecular target remains under investigation; analogs and blends require separate characterization.

Adamantane & the blood–brain barrier

Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.

08 / LIFESTYLE FACTORS

Lifestyle Factors

  • Sleep: aim for 7–9 hours; the largest natural GH pulse happens in deep sleep.
  • Fasted dosing: dose away from meals — elevated insulin and carbs blunt the GH pulse.
  • Training: pair with resistance training and real recovery days.
  • Protein: keep protein intake adequate to support lean mass.
  • Consistency: dose at the same time each day and rotate injection sites.

09 / BENEFITS & SIDE EFFECTS

Potential Benefits & Side Effects

Potential Benefits

  • Deeper, more restorative sleep
  • Improved recovery from training
  • Gradual improvements in body composition (more lean mass, less fat)
  • Better skin, hair and overall vitality reported over longer cycles

Side Effects

  • Injection-site redness or irritation
  • Water retention, tingling or numbness in hands
  • Head rush, flushing or lightheadedness shortly after dosing
  • Increased hunger (more with ghrelin-pathway peptides)
  • Higher blood sugar at larger doses — monitor glucose and IGF-1

10 / STUDIES

Studies & references

11 / SAFETY

Safety considerations

  • Verify the active identity, lot number, and matching certificate of analysis. Testing does not by itself establish sterility or suitability for human use.
  • Follow documented product-specific storage and preparation requirements; stability and diluent compatibility depend on the formulation.
  • Research powders are not interchangeable with prescription formulations. Do not infer an injection or nasal protocol from a concentration calculation.
  • For medical care, pregnancy, existing conditions, or medication interactions, consult a qualified healthcare professional.

12 / RECOMMENDED SOURCE

Recommended Source

For research peptides, we point researchers to Orbitrex Peptides for CJC-1295 (no DAC) + IPA.

Why Orbitrex?

  • Family-owned & independently tested: Multiple laboratories verify quality, with batch-specific testing in every COA.
  • Everyday value: Buy 4, Get 1 Free on eligible products.
  • Loyalty credit: 5% back in loyalty credit for future purchases.
  • VerifyPass discount: 20% off for qualifying groups — stacks with affiliate codes.
  • Free 2nd Day shipping: Free UPS 2nd Day Air on orders $200+, applied automatically at checkout.

All products are for research use only. Availability and offers subject to change.